Prett

Copenhagen, Denmark

PreTT is revolutionizing the treatment of cancer by using sophisticated radioligand therapies that outperform conventional techniques.

$540K raised

Feb 2024

Convertible Note

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Prett raised?

Prett has raised $540K in total funding. The most recent round was Convertible Note. The last funding was announced in February 2024.

Who are Prett's investors?

Prett's investors include BioInnovation Institute.

Where is Prett headquartered?

Prett is headquartered in Copenhagen, Denmark.

What does Prett do?

PreTT is revolutionizing the treatment of cancer by using sophisticated radioligand therapies that outperform conventional techniques.

What stage is Prett at?

Prett is at the Convertible Note stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated February 29, 2024.

MLA

"Prett — Funding & Investors." VCBacked, February 29, 2024, https://www.vcbacked.co/company/prett. Accessed July 2, 2026.

APA

VCBacked. (2024). Prett — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/prett

Wikipedia (cite web)

{{cite web |title=Prett — Funding & Investors |url=https://www.vcbacked.co/company/prett |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated February 29, 2024.